TABLE 4.
Male | Female | |||
---|---|---|---|---|
Coefficient (SE) | SD (SE) | Coefficient (SE) | SD (SE) | |
Effect 70% | 1.486 (0.076)*** | 0.593 (0.111)*** | 1.544 (0.073)*** | 0.225 (0.184) |
Effect 90% | 3.279 (0.147)*** | 1.954 (0.129)*** | 3.391 (0.149)*** | 0.265 (0.187)*** |
Duration 12 mo | 0.464 (0.06)*** | 0.011 (0.101) | 0.564 (0.059)*** | 1.866 (0.131) |
Duration 18 mo | 0.601 (0.072)*** | 0.351 (0.135)* | 0.955 (0.079)*** | 0.081 (0.116)*** |
Moderate adverse event | 0.524 (0.062)*** | 0.075 (0.136) | 0.444 (0.07)*** | 0.6 (0.123)*** |
No adverse event | 0.951 (0.079)*** | 0.93 (0.096)** | 1.157 (0.085)*** | 0.71 (0.1)*** |
Injection 2 times | −0.04 (0.065) | 0.319 (0.137) | 0.164 (0.066)*** | 1.156 (0.097) |
Injection 1 time | 0.076 (0.059) | 0.066 (0.158) | 0.286 (0.062)* | 0.083 (0.115)* |
Imported | 0.198 (0.045)*** | 0.085 (0.173) | 0.176 (0.046)*** | 0.317 (0.127) |
Price | −0.001 (0.001)*** | 0.002 (0.001)*** | −0.002 (0.001)*** | 0.213 (0.113)*** |
Urban resident | Rural resident | |||
---|---|---|---|---|
Coefficient (SE) | SD (SE) | Coefficient (SE) | SD (SE) | |
Effect 70% | 1.488 (0.058)*** | 0.372 (0.102)*** | 1.44 (0.11)*** | 0.564 (0.191)** |
Effect 90% | 3.235 (0.109)*** | 1.805 (0.101)*** | 3.208 (0.227)*** | 2.087 (0.233)*** |
Duration 12 mo | 0.499 (0.047)*** | 0.041 (0.086) | 0.554 (0.089)*** | 0.1 (0.148) |
Duration 18 mo | 0.718 (0.056)*** | 0.326 (0.122)** | 0.832 (0.118)** | 0.683 (0.182)*** |
Moderate adverse event | 0.528 (0.052)*** | 0.423 (0.096)*** | 0.324 (0.093)*** | 0.196 (0.24) |
No adverse event | 1.043 (0.064)*** | 0.933 (0.078)*** | 1.137 (0.126)*** | 0.968 (0.176)*** |
Injection 2 times | 0.065 (0.051) | 0.02 (0.148) | 0.099 (0.095) | 0.07 (0.178) |
Injection 1 time | 0.142 (0.048)** | 0.144 (0.128) | 0.323 (0.09)*** | 0.309 (0.202) |
Imported | 0.154 (0.036)*** | 0.299 (0.07)*** | 0.331 (0.068)*** | 0.192 (0.141) |
Price | −0.002 (0.001)*** | 0.002 (0)*** | −0.002 (0.001)*** | 0.002 (0.001)*** |
Had children | No children | |||
---|---|---|---|---|
Coefficient (SE) | SD (SE) | Coefficient (SE) | SD (SE) | |
Effect 70% | 1.558 (0.071)*** | 0.448 (0.126)*** | 1.411 (0.081)*** | 0.517 (0.127)*** |
Effect 90% | 3.426 (0.139)*** | 2.015 (0.138)*** | 3.001 (0.141)*** | 1.782 (0.137)*** |
Duration 12 months | 0.483 (0.057)*** | 0.081 (0.098) | 0.57 (0.065)*** | 0.123 (0.118) |
Duration 18 months | 0.77 (0.072)*** | 0.606 (0.113)*** | 0.727 (0.076)*** | 0.292 (0.215) |
Moderate adverse event | 0.546 (0.06)*** | 0.072 (0.155) | 0.413 (0.067)*** | 0.211 (0.295) |
No adverse event | 0.991 (0.076)*** | 0.947 (0.092)*** | 1.176 (0.094)*** | 1.092 (0.101)*** |
Injection 2 times | 0.031 (0.062) | 0.126 (0.129) | 0.105 (0.069) | 0.27 (0.145) |
Injection 1 time | 0.175 (0.058)* | 0.336 (0.118)** | 0.176 (0.063)* | 0.115 (0.248) |
Imported | 0.169 (0.043)*** | 0.286 (0.102)** | 0.204 (0.049)*** | 0.326 (0.088)*** |
Price | −0.002 (0.001)*** | 0.002 (0.001)*** | −0.002 (0.001)*** | 0.002 (0.001)*** |
Vaccinated | Non‐vaccinated | |||
---|---|---|---|---|
Coefficient (SE) | SD (SE) | Coefficient (SE) | SD (SE) | |
Effect 70% | 1.601 (0.065)*** | 0.212 (0.157) | 1.259 (0.079)*** | 0.584 (0.128)*** |
Effect 90% | 3.434 (0.129)*** | 1.911 (0.119) | 2.912 (0.151)*** | 1.809 (0.145)*** |
Duration 12 months | 0.515 (0.053)*** | 0.116 (0.108) | 0.487 (0.066)*** | 0.051 (0.118) |
Duration 18 months | 0.751 (0.066)*** | 0.392 (0.142) | 0.74 (0.081)*** | 0.473 (0.128)*** |
Moderate adverse event | 0.512 (0.057)*** | 0.22 (0.167) | 0.423 (0.071)*** | 0.192 (0.133) |
No adverse event | 1.064 (0.077)*** | 1.058 (0.088) | 1.087 (0.088)*** | 0.905 (0.107)*** |
Injection 2 times | 0.037 (0.058) | 0.211 (0.158) | 0.094 (0.072) | 0.091 (0.132) |
Injection 1 time | 0.149 (0.054)* | 0.222 (0.151) | 0.193 (0.067)* | 0.228 (0.133) |
Imported | 0.179 (0.041)*** | 0.175 (0.094) | 0.194 (0.053)*** | 0.45 (0.084)*** |
Price | −0.002 (0.001)*** | 0.002 (0.001) | −0.002 (0.001)*** | 0.002 (0.001)*** |
Abbreviations: SE, standard error; SD standard deviation.
<0.05;
<0.01;
<0.001.